BRUNETTI, JLENIA
 Distribuzione geografica
Continente #
EU - Europa 4.634
NA - Nord America 4.388
AS - Asia 742
AF - Africa 11
OC - Oceania 11
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.800
Nazione #
US - Stati Uniti d'America 4.367
GB - Regno Unito 1.283
IT - Italia 1.038
IE - Irlanda 718
CN - Cina 406
SE - Svezia 357
RU - Federazione Russa 288
UA - Ucraina 270
DE - Germania 205
FR - Francia 177
SG - Singapore 137
FI - Finlandia 100
VN - Vietnam 71
ES - Italia 59
BE - Belgio 42
IN - India 24
PL - Polonia 21
IR - Iran 20
CZ - Repubblica Ceca 18
CA - Canada 17
TR - Turchia 17
HK - Hong Kong 13
NL - Olanda 10
AT - Austria 9
AU - Australia 8
PK - Pakistan 8
PH - Filippine 7
RO - Romania 7
CH - Svizzera 6
CI - Costa d'Avorio 6
IL - Israele 6
JP - Giappone 5
PE - Perù 5
BD - Bangladesh 4
DK - Danimarca 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EE - Estonia 3
EG - Egitto 3
EU - Europa 3
JO - Giordania 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SA - Arabia Saudita 3
AR - Argentina 2
AZ - Azerbaigian 2
BR - Brasile 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
MA - Marocco 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
MT - Malta 1
MY - Malesia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 9.800
Città #
Southend 1.208
Dublin 708
Fairfield 567
Chandler 402
Siena 382
Ashburn 350
Woodbridge 277
Ann Arbor 272
Seattle 224
Houston 221
Jacksonville 221
Santa Clara 202
Wilmington 202
Menlo Park 171
Cambridge 159
Singapore 110
Beijing 105
Princeton 104
New York 76
Dong Ket 70
Nanjing 69
Boardman 63
Florence 55
Helsinki 54
Málaga 48
Rome 46
San Diego 39
Fremont 37
Shanghai 37
Brussels 35
Dearborn 32
Nanchang 31
San Mateo 30
Hebei 26
Milan 25
Shenyang 22
Bagno a Ripoli 21
Washington 21
London 18
Moscow 17
Brno 16
Los Angeles 15
Redwood City 15
Tianjin 15
Gdansk 14
Naples 14
Chicago 13
Kunming 12
Izmir 11
Phoenix 11
Dallas 10
Lappeenranta 10
Toronto 9
Vienna 9
Jiaxing 8
Jinan 8
Ningbo 8
Arezzo 7
Atlanta 7
Changsha 7
Colle Di Val D'elsa 7
Columbus 7
Hong Kong 7
Munich 7
Norwalk 7
Zanjan 7
Abidjan 6
Barcelona 6
Düsseldorf 6
Napoli 6
Salerno 6
Campagnano Di Roma 5
Guangzhou 5
Leawood 5
Lima 5
Overijse 5
Palermo 5
Radomsko 5
San Francisco 5
Tappahannock 5
Turin 5
University Park 5
Como 4
Council Bluffs 4
Delhi 4
Frankfurt am Main 4
Fuzhou 4
Grosseto 4
Hangzhou 4
Kilburn 4
Manila 4
Monteriggioni 4
Nürnberg 4
Paris 4
Pontedera 4
Pune 4
Seravezza 4
Stockholm 4
Taizhou 4
Zhengzhou 4
Totale 7.175
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 271
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 262
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 257
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 256
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 237
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 234
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 226
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 217
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 210
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 209
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 206
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 203
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 201
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 201
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 199
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 197
A new NT4 peptide-based drug delivery system for cancer treatment 179
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 177
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 175
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 174
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 173
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 170
Branched peptides as bioactive molecules for drug design 167
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 167
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 166
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 165
null 165
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 159
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 158
Branched peptides as targeting agents for tumor imaging and therapy 150
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 148
Nanoparticles exposing neurotensin tumor-specific drivers 146
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 144
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 143
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 138
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 137
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 136
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 131
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 129
Branched Neurotensin peptides for tumor personalized therapy 127
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 124
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 124
The antimicrobial peptide M33. An example of drug development 123
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 123
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 123
Tumor selective targeting by branched peptides 119
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 118
The antimicrobial peptide M33. An example of drug development 117
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 114
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells 111
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 109
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 108
The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly 107
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 106
null 105
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 102
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 98
A selective Nile Red based solvatochromic probe: A study of fluorescence in LUVs and GUVs model membranes 96
The Intraflagellar Transport Protein IFT20 Recruits ATG16L1 to Early Endosomes to Promote Autophagosome Formation in T Cells 90
Light-Switchable Membrane Permeability in Giant Unilamellar Vesicles 80
null 78
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 70
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 59
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 58
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 51
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 46
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 44
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 40
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 34
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 20
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 20
Editorial: Proteoglycans in the Tumor Microenvironment 7
Totale 10.034
Categoria #
all - tutte 32.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020893 0 0 0 0 0 132 137 163 155 154 58 94
2020/20211.685 72 105 35 130 66 198 201 214 119 283 106 156
2021/20221.157 71 98 65 100 99 61 57 66 57 145 129 209
2022/20231.493 76 155 180 194 170 248 45 133 111 66 68 47
2023/20241.317 39 33 108 84 75 366 414 35 10 33 30 90
2024/2025936 77 100 309 125 305 20 0 0 0 0 0 0
Totale 10.034